Profil bibliographique

Sandra Navarra

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

186Publications signalées

9505Citations signalées

1Affiliations récentes

Institutions déclarées

Domaines associés

Systemic Lupus Erythematosus ResearchRheumatoid Arthritis Research and TherapiesMultiple Sclerosis Research StudiesSystemic Sclerosis and Related DiseasesLiver Diseases and Immunity

Publications récentes

2026 articleOpenAlex

Longitudinal comparison of treat-to-target states and clinical outcomes in patients with late-onset versus early-onset systemic lupus erythematosus

Worawit Louthrenoo, Alberta Hoi, Vera Golder, Yi‐Hsing Chen et autres

0 citationsThe Journal of Rheumatology

2026 articleOpenAlex

Calcinosis Cutis in Sjögren's Syndrome With Interstitial Lung Disease

Norwin Philip L. Bation, Jan Mark T. Antenor, Sandra Navarra

0 citationsInternational Journal of Rheumatic Diseases

Accès ouvert 2026 articleOpenAlex

Predictive correlates of arthritis and joint damage in systemic lupus erythematosus: a multinational prospective cohort study

Luigi Zolio, Yanjie Hao, Rangi Kandane Rathnayake, Worawit Louthrenoo et autres

0 citationsLara D. Veeken

2026 articleOpenAlex

Case Report: Successful Treatment of Refractory Relapsing Polychondritis with Anti‐CD20 Therapies

Fayanne Patricia K. Lim, Sandra Navarra

0 citationsInternational Journal of Rheumatic Diseases

Accès ouvert 2026 articleOpenAlex

Demographic and clinical characteristics of patients with systemic lupus erythematosus across five registries: the LupusNet federated data network

F. Zazzetti, Ashley Orillion, U. Sbarigia, Anna Sheahan et autres

0 citationsLupus Science & Medicine

Accès ouvert 2026 preprintOpenAlex

Evaluation of Candidate Definitions of Severe Refractory Systemic Lupus Erythematosus Using Clinical Outcomes: Real-World Data Exploration Study

Rangi Kandane‐Rathnayake, Vera Golder, Worawit Louthrenoo, Yi‐Hsing Chen et autres

0 citationsSSRN Electronic Journal

Accès ouvert 2025 articleOpenAlex

Long-term safety and efficacy of voclosporin in Asian patients with lupus nephritis: A post hoc analysis of the AURORA 2 trial

Tatsuya Atsumi, Sandra Navarra, Eisuke Nakata, Haruka Matsukawa

0 citationsModern Rheumatology

Accès ouvert 2025 articleOpenAlex

Predictors of damage accrual by organ domain in systemic lupus erythematosus

Rangi Kandane‐Rathnayake, Luigi Zolio, Jiyoon Choi, Vera Golder et autres

2 citationsLara D. Veeken

2025 articleOpenAlex

Prospective Randomized Controlled 96-week Study to Evaluate the Efficacy and Safety of Tacrolimus and Glucocorticoid as Continuous Induction-Maintenance Treatment for Class III/IV±V Lupus Nephritis

Tak Mao Chan, Yat Hin Desmond Yap, Zhaohui Ni, Yingyos Avihingsanon et autres

0 citationsJournal of the American Society of Nephrology

Accès ouvert 2025 articleOpenAlex

Prevalence, Determinants, and Outcomes of Low Disease Activity and Remission Attainment in Patients With Systemic Lupus Erythematosus That Is Clinically Active

Yanjie Hao, Dylan Hansen, Rangi Kandane‐Rathnayake, Worawit Louthrenoo et autres

0 citationsArthritis Care & Research

Accès ouvert 2025 articleOpenAlex

Informing trial measurement in systemic lupus erythematosus: frequency of domain-specific disease activity in a multinational cohort

Raychel Barallon, Kathryn Connelly, Vera Golder, Worawit Louthrenoo et autres

2 citationsLupus Science & Medicine

Accès ouvert 2025 articleOpenAlex

Impact of glucocorticoid dose threshold in definition of lupus low disease activity state: a multinational observational cohort study

Rangi Kandane‐Rathnayake, Alberta Hoi, Worawit Louthrenoo, Vera Golder et autres

0 citationsLupus Science & Medicine

Profil ORCID Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.